AQP1 and ovarian serous adenocarcinoma: In our current study, we discovered overexpression of AQP1 mRNA was associated with poor OS for all ovarian cancer patients, especially for serous ovarian cancer, with well and moderate differentiation (pathological grades I and II) as well as in all clinical stages (I–IV).